Chief Executive Officer (CEO)
Dr. Alexis K. Okoh is a physician-scientist with a subspeciality in Cadiology. He has extensive experience in designing and running clinical trials with an emphasis on underserved communities. He leads the global effort to expand cardiovascular are through reserch, innovation and stsem-level solutions in underserved regions
Chief Medical Officer (CMO)
Dr. Michael Kwesi Amponsah is a distinguished structural interventional cardiologist with clinical practices spanning both the United States and Ghana (West Africa). As CEO of the Global Access to Cardiovascular Therapeutics and Diagnotics (G-ACT) Foundation, he brings a strategic focus on delivering high-impact cardiovascular care in resource-constrained environments.
Chief Operating Officer (COO)
Dr. Lambert Tetteh Appiah is an internationally recognized physician-scientist, cardiovascular disease expert and global health strategist. As Chief Operations Officer of the Global Access to Cardiovascular Therapeutics and Diagnostics (G-ACT) Foundation, he oversees operational strategy and execution, driving the delivery of sustainable cardiovascular care to underserved regions
Chief Innovation Officer (CIO)
Dr. Serti Fugar is an accomplished interventional cardiologist, educator and global health advocate. As Chief Medical Officer of the Global Access to Cardiovascular Therapeutics and Diagnostics (G-ACT) Foundation, he leads the organization's clinical strategy to expand equitable, evidence-based cardiovascular care in underserved communities worldwide.
Clinical quality without compromise
Partnerships that amplify impact
Technology serving humanity
Healthcare access for all
“Where someone lives should never determine whether they live.”
